Erika Ferrari Selected Research

Diarylheptanoids

2/2019	Development of a Potential Gallium-68-Labelled Radiotracer Based on DOTA-Curcumin for Colon-Rectal Carcinoma: From Synthesis to In Vivo Studies.
1/2017	Uptake of Ga-curcumin derivatives in different cancer cell lines: Toward the development of new potential 68Ga-labelled curcuminoids-based radiotracers for tumour imaging.
9/2016	Affinity of (nat/68)Ga-Labelled Curcumin and Curcuminoid Complexes for β-Amyloid Plaques: Towards the Development of New Metal-Curcumin Based Radiotracers.
11/2014	Antibacterial phototoxic effects of synthetic asymmetric and glycosylated curcuminoids in aqueous formulations: studies on curcumin and curcuminoids. LIV.
10/2014	Curcumin derivatives as metal-chelating agents with potential multifunctional activity for pharmaceutical applications.
5/2014	Synthesis and characterization of (68)Ga-labeled curcumin and curcuminoid complexes as potential radiotracers for imaging of cancer and Alzheimer's disease.
10/2009	Synthesis and characterization of glucosyl-curcuminoids as Fe3+ suppliers in the treatment of iron deficiency.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Erika Ferrari Research Topics

Disease

8	Neoplasms (Cancer) 11/2021 - 11/2009
5	Alzheimer Disease (Alzheimer's Disease) 07/2021 - 05/2014
3	Carcinoma (Carcinomatosis) 02/2019 - 04/2009
2	Colonic Neoplasms (Colon Cancer) 01/2021 - 01/2013
2	Iron Deficiencies 10/2009 - 11/2008
1	Lymphoma (Lymphomas) 02/2019
1	Colorectal Neoplasms (Colorectal Cancer) 02/2019
1	Prostatic Neoplasms (Prostate Cancer) 12/2018
1	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2018
1	Infections 01/2017
1	Amyloid Plaque 09/2016
1	Phototoxic Dermatitis (Phototoxicity) 11/2014
1	Lung Neoplasms (Lung Cancer) 05/2014

Drug/Important Bio-Agent (IBA)

12	CurcuminIBA 07/2021 - 04/2009
7	DiarylheptanoidsIBA 02/2019 - 10/2009
3	Proteins (Proteins, Gene)FDA Link 01/2021 - 01/2018
3	Amyloid (Amyloid Fibrils)IBA 01/2018 - 05/2014
2	Fluorine-18IBA 09/2016 - 05/2014
2	bis-dehydroxy-curcuminIBA 09/2016 - 01/2013
2	MetalsIBA 09/2016 - 10/2014
2	LigandsIBA 10/2009 - 11/2008
1	TegafurIBA 01/2021
1	Pharmaceutical PreparationsIBA 01/2021
1	Gallium-68IBA 02/2019
1	1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acidIBA 02/2019
1	phthalimideIBA 12/2018
1	Amyloid beta-PeptidesIBA 01/2017
1	bis-dehydroxycurcumin tert-butyl esterIBA 01/2017
1	Diacetyl (Biacetyl)IBA 09/2016
1	N-acetyltalosaminuronic acid (NAT)IBA 09/2016
1	Poloxamer (Poloxamer 407)IBA 11/2014
1	EstersIBA 12/2011
1	DNA (Deoxyribonucleic Acid)IBA 11/2009
1	Cisplatin (Platino)FDA LinkGeneric 04/2009
1	Glucose (Dextrose)FDA LinkGeneric 04/2009
1	Biological ProductsIBA 11/2008
1	AcidsIBA 11/2008

Therapy/Procedure

3	Therapeutics 12/2018 - 10/2014
1	Endoscopes 11/2021
1	Lab-On-A-Chip Devices 01/2021
1	Drug Therapy (Chemotherapy) 12/2018
1	Castration 12/2018
1	Photochemotherapy (Photodynamic Therapy) 01/2017